Stockscreener 앱 받기
0.7901
10.05%
-0.0883
시간 외 거래:
.80
0.0099
+1.25%
전일 마감가:
$0.8784
열려 있는:
$0.8601
하루 거래량:
2.83M
Relative Volume:
1.47
시가총액:
$3.79M
수익:
-
순이익/손실:
$-14.07M
주가수익비율:
-0.0565
EPS:
-13.99
순현금흐름:
$-12.56M
1주 성능:
-21.77%
1개월 성능:
+9.58%
6개월 성능:
-36.79%
1년 성능:
-78.29%
1일 변동 폭
$0.771
$0.8606
1주일 범위
$0.771
$1.90
52주 변동 폭
$0.60
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
명칭
Palisade Bio Inc
전화
(858) 704-4900
주소
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
PALI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
0.7901 | 5.00M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc 주식(PALI)의 최신 뉴스
Can you recover from losses in Palisade Bio Inc.Buy Alert Based on RSI and Volume - Newser
Is Palisade Bio Inc. stock poised for growthFree Confirmed Setup With Expert Accuracy - Newser
How Palisade Bio Inc. stock performs during market volatilityAlgorithmic Prediction of Market Breakouts - Newser
Palisade Bio (PALI) to Release Earnings on Monday - Defense World
Palisade Bio Inc. stock trendline breakdownFree Reliable Investment Entry Point Signals - Newser
What makes Palisade Bio Inc. stock price move sharplyDaily Profit Watch With Forecast Confidence - Newser
Recovery Signals Appearing in Palisade Bio Inc. ChartsPotential Breakout Stock List Published This Week - beatles.ru
Palisade Bio Soars on Breakthrough Ulcerative Colitis Data: What Investors Need to Know - RagingBull
Is Palisade Bio Poised to Rise? - StocksToTrade
Palisade Bio reports positive data for UC drug PALI-2108 By Investing.com - Investing.com Australia
Palisade Bio Inc.’s Stock Climbs Amid Patent News: What’s Next? - timothysykes.com
Palisade Bio Reports 100% Clinical Response in Phase 1b - GlobeNewswire
Novel PDE4 Inhibitor Achieves 100% Response Rate in Phase 1b Ulcerative Colitis Trial | PALI Stock News - Stock Titan
When is the best time to buy Palisade Bio Inc. stockShort-Term Trade Setup with Forecast Insight - Newser
Institutional scanner results for Palisade Bio Inc.Real Time Screener for Growth Trades - Newser
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis - TipRanks
Applying Elliott Wave Theory to Palisade Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser
Applying chart zones and confluence areas to Palisade Bio Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Palisade Bio Inc. Builds Base for Possible ReboundLow Risk High Return Opportunities Identified - metal.it
Is it the right time to buy Palisade Bio Inc. stockPowerful growth strategies - Jammu Links News
What analysts say about Palisade Bio Inc. stockBuild wealth steadily with proven investment techniques - Jammu Links News
How does Palisade Bio Inc. compare to its industry peersIdentify winners with top-tier analysis - Jammu Links News
Is Palisade Bio Inc. a growth stock or a value stockMaximize your returns with smart trade entries - Jammu Links News
Heatmap analysis for Palisade Bio Inc. and competitorsConservative Investment Setup and Risk Analysis - Newser
Should I hold or sell Palisade Bio Inc. stock in 2025Skyrocketing investment returns - Jammu Links News
What are Palisade Bio Inc. company’s key revenue driversMarket-crushing stock picks - Jammu Links News
What institutional investors are buying Palisade Bio Inc. stockExceptional portfolio growth - Jammu Links News
How does Palisade Bio Inc. generate profit in a changing economyGet daily updates on promising stocks - Jammu Links News
When is Palisade Bio Inc. stock expected to show significant growthInvest confidently with expert support - Jammu Links News
What catalysts could drive Palisade Bio Inc. stock higher in 2025Free Capital Efficiency Planning - Jammu Links News
How sentiment analysis helps forecast Palisade Bio Inc.Buy and Hold Position Summary Review - Newser
What is the risk reward ratio of investing in Palisade Bio Inc. stockTop Growth Review With High Returns - Jammu Links News
Intraday pattern recognizer results for Palisade Bio Inc.Free Real Market Momentum Signal Generator - Newser
Palisade Bio Receives Notice of Allowance for Composition - GlobeNewswire
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment - MSN
Palisade Bio secures patent allowance in China for PALI-2108 By Investing.com - Investing.com Nigeria
Palisade Bio secures patent allowance in China for PALI-2108 - Investing.com
Novel IBD Drug Gets 20-Year China Patent Protection: $1B Market Opportunity for First-in-Class Treatment - Stock Titan
Palisade Bio Inc (PALI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):